BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 23557224)

  • 21. Corneal Breakthrough Haze After Photorefractive Keratectomy With Mitomycin C: Incidence and Risk Factors.
    Kaiserman I; Sadi N; Mimouni M; Sela T; Munzer G; Levartovsky S
    Cornea; 2017 Aug; 36(8):961-966. PubMed ID: 28542088
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Photorefractive keratectomy with mitomycin-C for the treatment of compound moderate myopia with astigmatism in buccal pemphigus vulgaris.
    Taheri SM; Kheiltash A
    J Cataract Refract Surg; 2007 Oct; 33(10):1819-22. PubMed ID: 17889785
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Visually significant haze after retreatment with photorefractive keratectomy with mitomycin-C following laser in situ keratomileusis.
    Liu A; Manche EE
    J Cataract Refract Surg; 2010 Sep; 36(9):1599-601. PubMed ID: 20692575
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Corneal wavefront-guided photorefractive keratectomy with mitomycin-C for hyperopia after radial keratotomy: two-year follow-up.
    Ghanem RC; Ghanem VC; Ghanem EA; Kara-José N
    J Cataract Refract Surg; 2012 Apr; 38(4):595-606. PubMed ID: 22440434
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nerve growth factor concentration and implications in photorefractive keratectomy vs laser in situ keratomileusis.
    Lee HK; Lee KS; Kim HC; Lee SH; Kim EK
    Am J Ophthalmol; 2005 Jun; 139(6):965-71. PubMed ID: 15953424
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mitomycin-C in hyperopic photorefractive keratectomy.
    Leccisotti A
    J Cataract Refract Surg; 2009 Apr; 35(4):682-7. PubMed ID: 19304089
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intraocular straylight before and after low myopic photorefractive keratectomy with and without mitomycin C.
    Torricelli AA; Parede TR; Netto MV; Crestana FP; Bechara SJ
    Arq Bras Oftalmol; 2016 Apr; 79(2):88-91. PubMed ID: 27224070
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Photorefractive keratectomy with mitomycin-C for the combined treatment of myopia and subepithelial infiltrates after epidemic keratoconjunctivitis.
    Alevi D; Barsam A; Kruh J; Prince J; Perry HD; Donnenfeld ED
    J Cataract Refract Surg; 2012 Jun; 38(6):1028-33. PubMed ID: 22624902
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Spherical and aspherical photorefractive keratectomy and laser in-situ keratomileusis for moderate to high myopia: two prospective, randomized clinical trials. Summit technology PRK-LASIK study group.
    Steinert RF; Hersh PS
    Trans Am Ophthalmol Soc; 1998; 96():197-221; discussion 221-7. PubMed ID: 10360290
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Wavefront-guided photorefractive keratectomy in eyes with prior radial keratotomy: a multicenter study.
    Koch DD; Maloney R; Hardten DR; Dell S; Sweeney AD; Wang L
    Ophthalmology; 2009 Sep; 116(9):1688-1696.e2. PubMed ID: 19643486
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of hinge position on corneal sensation and dry eye parameters after femtosecond laser-assisted LASIK.
    Huang JC; Sun CC; Chang CK; Ma DH; Lin YF
    J Refract Surg; 2012 Sep; 28(9):625-31. PubMed ID: 22947290
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intraoperative mitomycin and corneal endothelium after photorefractive keratectomy.
    Morales AJ; Zadok D; Mora-Retana R; Martínez-Gama E; Robledo NE; Chayet AS
    Am J Ophthalmol; 2006 Sep; 142(3):400-4. PubMed ID: 16935583
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Astigmatism: risk factor for postoperative corneal haze in conventional myopic photorefractive keratectomy.
    Thomas KE; Brunstetter T; Rogers S; Sheridan MV
    J Cataract Refract Surg; 2008 Dec; 34(12):2068-72. PubMed ID: 19027561
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of standard (0.02%) and low dose (0.002%) mitomycin C in the prevention of corneal haze following surface ablation for myopia.
    Thornton I; Xu M; Krueger RR
    J Refract Surg; 2008 Jan; 24(1):S68-76. PubMed ID: 18269154
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of the prophylactic use of mitomycin-C to inhibit haze formation after photorefractive keratectomy in high myopia: a prospective clinical study.
    Hashemi H; Taheri SM; Fotouhi A; Kheiltash A
    BMC Ophthalmol; 2004 Sep; 4():12. PubMed ID: 15363107
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Corneal barrier function, tear film stability, and corneal sensation after photorefractive keratectomy and laser in situ keratomileusis.
    Nejima R; Miyata K; Tanabe T; Okamoto F; Hiraoka T; Kiuchi T; Oshika T
    Am J Ophthalmol; 2005 Jan; 139(1):64-71. PubMed ID: 15652829
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Randomized bilateral comparison of excimer laser in situ keratomileusis and photorefractive keratectomy for 2.50 to 8.00 diopters of myopia.
    El-Maghraby A; Salah T; Waring GO; Klyce S; Ibrahim O
    Ophthalmology; 1999 Mar; 106(3):447-57. PubMed ID: 10080199
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Impact of Photorefractive Keratectomy and Mitomycin C on Corneal Nerves and Their Regeneration.
    Medeiros CS; Marino GK; Lassance L; Thangavadivel S; Santhiago MR; Wilson SE
    J Refract Surg; 2018 Dec; 34(12):790-798. PubMed ID: 30540361
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Photorefractive keratectomy with intraoperative mitomycin-C application.
    Lee DH; Chung HS; Jeon YC; Boo SD; Yoon YD; Kim JG
    J Cataract Refract Surg; 2005 Dec; 31(12):2293-8. PubMed ID: 16473220
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Photorefractive keratectomy for refractory laser in situ keratomileusis flap striae.
    Kuo IC; Jabbur NS; O'Brien TP
    J Cataract Refract Surg; 2008 Feb; 34(2):330-3. PubMed ID: 18242463
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.